University of Iowa Healthcare
Iowa City, Iowa, 52242, United States
Location status: Recruiting
Location contact
Bruce Gantz, MD
PRINCIPAL_INVESTIGATOR
Camille Dunn, PhD
CONTACT
Rachel Scheperle, PhD
CONTACT
NCT Number: NCT06951594
Robotics-assisted electrode insertion overcomes many surgeon-related kinetic limitations such as insertion speed, tremor, drift, and lack of accurate force control. In human cadaveric cochleae, robotics-assisted electrode insertion causes less intracochlear trauma compared to manual insertion. Whether this technical advance results in functional benefits in CI patients remains unknown. To address this critical knowledge gap, the investigators will compare cochlear trauma assessed using CT scans, cochlear and AN function assessed using ECochG and/or the eCAP, and clinical outcomes quantified by postoperative residual acoustic hearing and speech perception scores between participants randomized to either manual or robotics-assisted electrode array insertion.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Iowa City, Iowa, 52242, United States
Location status: Recruiting
Bruce Gantz, MD
PRINCIPAL_INVESTIGATOR
Camille Dunn, PhD
CONTACT
Rachel Scheperle, PhD
CONTACT
Electrode insertion force is a critical determinant of the degree/amount of intracochlear trauma caused by CI surgery. It is affected by the speed of electrode array insertion, with higher insertion speeds leading to greater insertion forces. In addition, rapid electrode array insertions with higher forces are associated with translocation of electrode arrays from the scala tympani into the scala media or vestibuli which leads to lower performance and higher rates of loss of residual hearing. Furthermore, variability in insertion force during electrode insertion can cause dramatic increases in intracochlear fluid pressure which appears to be traumatic. The recent FDA-approved iotaSOFT™ insertion system is designed to address these issues by controlling the speed of implant insertion (0.1-1.0 mm/sec) with reduced insertion force and variability. Use of the iotaSOFT™ insertion system significantly reduces the maximum insertion force, variation in insertion force and intracochlear pressure changes over time, which leads to decreased intracochlear trauma compared with manual insertion in cadavers. In addition, this robotics-assisted insertion system can be used with ECochG monitoring systems, which enables response dynamics that can dramatically reduce electrode array stopping distances (1-2 µm of further electrode array advancement) compared to the kinetics of human manual insertion (~1 mm) once a change in intraoperative ECochG response is detected. Theoretically, robotics-assisted electrode array insertion should result in better preserved structural and functional integrity of the peripheral auditory system due to reduced intracochlear trauma. However, this theoretical possibility has not been tested in human CI users.
To address this knowledge gap, the investigators propose to determine the functional benefits of using robotics-assisted electrode insertion in reducing intracochlear trauma. This will be achieved by comparing trauma to the cochlea from electrode insertion based on postoperative CT scans, electrode impedance, the functional status of the cochlea and the AN, as well as preservation of acoustic hearing in participants randomized to have the electrode array inserted manually or with the iotaSOFT™ insertion system. The investigators hypothesize that robotics-assisted electrode insertion will better preserve peripheral structural and functional integrity by reducing intraoperative trauma. The investigators expect that participants with robotics-assisted electrode insertions will show smaller trauma scores based on CT scans, lower electrode impedance, better functional statuses of the AN, higher ENI indices, less hearing loss, and improved speech perception scores than participants with manual electrode insertions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The iotaSOFT™ Insertion System is an FDA approved cochlear implant (CI) electrode array insertion tool. It provides surgeons with consistent insertion speed and force. The system consists of a drive unit connected to a touch screen control console and foot pedal interface. The surgeon secures the base to the skull with two pre-loaded self-drilling bone screws. The drive unit is placed into the base and the adjustable drive head is coupled to a CI electrode. Before insertion begins, the surgeon selects the desired speed of insertion. the surgeon controls the electrode insertion forward and reverse motion via foot pedal while guiding the electrode array into the cochlea with standard CI instrumentation. Upon the completion of electrode array insertion, the drive head and unit are uncoupled from the electrode lead and removed from the patient for disposal.
Time frame: Postoperative standard of care CT (approximately at activation or 2 weeks)
Postoperative CT scan will be used to assess scalar translocation
Time frame: Postoperative standard of care CT (approximately at activation or 2 weeks)
Angle of the electrode array inside the cochlea, measured relative to the round window membrane.
Time frame: initial activation and at 3 and 6 months post CI
resistance to the flow of current for each active electrode
Contact information is provided by the study sponsor or research team.
Camille Dunn, PhD
CONTACT
Rachel Scheperle, PhD
CONTACT
University of Iowa
Other
Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06375278
Cochlear Implantation, Cochlear Implants
Miami, Florida, United States
View Trial DetailsNCT07039435
Cochlear Implantation, Ear Diseases
New York, United States
View Trial DetailsNCT06040892
Cochlear Implantation, Ear Diseases
Lyon, France
View Trial DetailsNCT07380269
Cochlear Implantation, Deafness
Shanghai, China
View Trial Details